High-Growth Telemedicine Platform Serving the German Medical Cannabis Market

Cyprus-based company operating a fully remote, GDPR-compliant telemedicine and digital prescription platform serving the German medical cannabis market under the EU cross-border framework. Launched in 2024, the platform has connected about 20,000 patients with licensed physicians and pharmacies in Germany, with physicians licensed in Germany and Poland. It currently processes over 6,500 prescriptions per month and is built for scalability through automation and process optimization.

Business Highlights

Validated Demand and Momentum

• Approximately 20,000 patients served since launch (2024)
• Over 6,500 prescriptions processed per month

High-Margin, Multi-Stream Revenue

• Profit margins exceeding 60% (as stated)
• Revenue run rate around €125,000 per month, with a forecast of €1.5M by year-end
• Income from patient bookings, pharmacy marketing services, producer partnerships, and white-label offerings

Automation and Scalable Operations

• Automated workflows reduce doctor consultation time by about 90%
• Lean operating model with around 12 staff and freelancers
• White-label functionality supports rapid B2B expansion

Growth Levers Ready to Activate

• Built and optimized prior to heavier acquisition spend
• Plans and execution underway for targeted marketing (Facebook ads, affiliate marketing)
• Feature rollout continues to improve user experience and conversion

Investment Opportunity

Seeking full or majority sale. Includes the going concern business, intellectual property, brand, patient database, and software codebase. Positioned to benefit from rising demand tied to the evolving German medical cannabis landscape.

‍